[ad_1] Granules India Ltd. has informed the exchanges that the new product approvals from its crucial Gagillapur facility in Andhra Pradesh could be impacted after the US Food & Drug Administration (USFDA) classified the facility as an Official Action Indicated (OAI) on Tuesday, December 3. Company Value Change %Change “This classification does not impact the […]
Granules India’s loss is which pharma company’s gain? – CNBC TV18
[ad_1] Granules India Ltd.’s shares fell 10% on Tuesday after the USFDA granted an Official Action Indicated (OAI) status to its crucial Gagillapur facility, which had earlier received a form 483 with six observations. Company Value Change %Change An Official Action Indicated or OAI status means that a facility has objectionable conditions or practices that […]